Tesamorelin + Ipamorelin

Tesamorelin + Ipamorelin – Available in 18mg Vial

Dual-Pathway Research Blend for Growth Hormone Signalling & Endocrine Regulation

Tesamorelin + Ipamorelin combines two research peptides that interact with distinct pathways involved in growth hormone (GH) release and endocrine signalling. This combination is of interest in laboratory research exploring growth hormone regulation, pituitary signalling, and the interactions between complementary hormonal pathways.

Researchers study this pairing to investigate how growth hormone-releasing hormone (GHRH) receptor activation and growth hormone secretagogue receptor (GHS-R) signalling may influence growth hormone secretion and broader endocrine regulation.

Key Features

✓ Combines a GHRH analogue with a selective GH secretagogue

✓ Studied in relation to growth hormone signalling pathways

✓ Relevant to endocrine and pituitary research models

✓ Investigated in studies of growth hormone release dynamics

✓ Explores interactions between GHRH and ghrelin receptor pathways

✓ Relevant to growth hormone and IGF-1 signalling research

Why Researchers Study Tesamorelin + Ipamorelin

Dual Growth Hormone Signalling

Combines two peptides that act through distinct mechanisms associated with growth hormone regulation, providing a research framework for investigating interactions between GHRH receptor signalling and ghrelin receptor activation.

Growth Hormone Release Research

Investigated in research examining the regulation of growth hormone secretion, hormonal responses, and the signalling pathways involved in GH release.

Pituitary Function Studies

Tesamorelin and Ipamorelin are of interest in studies exploring pituitary responses to different hormonal signalling inputs and the mechanisms involved in endocrine regulation.

Endocrine Pathway Exploration

Provides a research context for examining interactions between GHRH-mediated signalling and growth hormone secretagogue receptor pathways.

Scientific Research Context

Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied for its role in stimulating growth hormone release through GHRH receptor signalling.

Research involving Tesamorelin focuses on:

• Growth hormone release mechanisms
• GHRH receptor signalling pathways
• Pituitary function and hormonal responses
• Growth hormone and IGF-1 relationships
• Endocrine feedback mechanisms

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R), also known as the ghrelin receptor.

Research involving Ipamorelin often focuses on:

• Ghrelin receptor signalling
• Growth hormone regulation
• Endocrine pathway modulation
• Hormone release dynamics
• Interactions between secretagogue signalling and pituitary responses

Because these peptides act through distinct mechanisms, their combined study may support investigations into how GHRH signalling and ghrelin receptor activation interact within the endocrine system. The effects of combining them should be established through appropriate research rather than assumed from their individual mechanisms.

Common Research Applications

Tesamorelin + Ipamorelin may be investigated in research models involving:

• Growth hormone secretion pathways
• Endocrine signalling and regulation
• Pituitary function and hormonal responses
• GH and IGF-1 signalling relationships
• Hormonal feedback mechanisms
• GHRH receptor pathway research
• Growth hormone secretagogue receptor studies
• Neuroendocrine signalling mechanisms

Related Research Peptides

Researchers investigating growth hormone and endocrine signalling pathways may also study:

• Tesamorelin – GHRH analogue research
• Ipamorelin – selective GH secretagogue research
• CJC-1295 – GHRH analogue research
• GHRP-6 – growth hormone secretagogue pathway research
• Sermorelin – GHRH signalling and pituitary research

These compounds are studied in broader investigations of endocrine regulation, hormone signalling, and pituitary function. Their mechanisms and research applications differ, and they should not be considered interchangeable.

Product Specifications

Product Name: Tesamorelin + Ipamorelin
Available Vial Sizes: 10mg and 20mg
Compound Type: Dual-Peptide Research Blend
Contains: Tesamorelin and Ipamorelin
Research Category: Growth Hormone & Endocrine Research
Primary Focus Areas: GH Signalling, Pituitary Function & Endocrine Regulation
Physical Form: Lyophilised (Freeze-Dried) Powder
Application: Research Use Only

Important Notice

For laboratory research purposes only. Not intended for human or veterinary use, self-administration, or use as a substitute for approved medical treatment. Product composition, purity, and compatibility should be independently verified.